BusinessFibrocell Announces Submission of Investigational New Drug Application for FCX-013 for the Treatment of Moderate to Severe Localized SclerodermaBy Nasdaq OMXFeb 5, 2018, 1:01 PM UTC
BusinessAxsome Therapeutics to Present at 2018 BIO CEO & Investor ConferenceBy Nasdaq OMXFeb 5, 2018, 12:00 PM UTC
BusinessCytokinetics to Announce Fourth Quarter Results on February 15, 2018By Nasdaq OMXFeb 2, 2018, 9:00 PM UTC
BusinessSENS Research Foundation Receives $2.4 Million Ethereum Donation From Vitalik ButerinBy Nasdaq OMXFeb 2, 2018, 4:00 PM UTC
BusinessNetworkNewsWire Announces Publication on Innovative Approaches in Non-Addictive AnalgesicsBy Nasdaq OMXFeb 2, 2018, 1:31 PM UTC
BusinessPredictive Technology Group, Inc. (PRED) Appoints Ronald Barhorst to Chair Its Financial Advisory BoardBy Nasdaq OMXFeb 1, 2018, 2:03 PM UTC
BusinessFilament Biosolutions Partners with Leading Canadian Academic Centers for $9.1M Project to Study Precision Nutritional Therapies for Inflammatory Bowel DiseaseBy Nasdaq OMXJan 31, 2018, 1:01 PM UTC
BusinessBiotagenics Partners with University of Ottawa and CHEO on a $9.1 Million Project with Genome Canada to Develop Therapies for Inflammatory Bowel DiseaseBy Nasdaq OMXJan 31, 2018, 12:30 PM UTC
